Lipospheres as carriers for topical delivery of aceclofenac: Preparation, characterization and In vivo evaluation

AAPS PharmSciTech

Volumn 9, Issue 1, 2008, Pages 154-162

  Nasr, Maha ^a   Mansour, Samar ^a   Mortada, Nahed D ^a   El Shamy, A A ^a  

^a Ain Shams University   (Egypt)

Author keywords

Aceclofenac; Animal experiment; Entrapment; Formulation; Lipospheres; Stability; Sustained release

Indexed keywords

ACECLOFENAC; BRISTAFLAM; DRUG CARRIER; LIPID; LIPOSPHERE; PHOSPHOLIPID; UNCLASSIFIED DRUG; DICLOFENAC; DRUG DERIVATIVE; LIPOSOME; NONSTEROID ANTIINFLAMMATORY AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG COATING; DRUG DOSAGE FORM COMPARISON; DRUG RELEASE; DRUG STABILITY; DRUG STORAGE; DRUG SYNTHESIS; ENCAPSULATION; IN VITRO STUDY; LOTION; MALE; MICROSCOPY; NONHUMAN; PARTICLE SIZE; PAW EDEMA; RAT; SCANNING ELECTRON MICROSCOPY; SOLVENT EFFECT; SUSTAINED RELEASE FORMULATION; ANIMAL; CHEMISTRY; DELAYED RELEASE FORMULATION; DIFFUSION; DRUG FORMULATION; DRUG SCREENING; EVALUATION; INFLAMMATION; MATERIALS TESTING; METHODOLOGY; PATHOLOGY; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DELAYED-ACTION PREPARATIONS; DICLOFENAC; DIFFUSION; DRUG COMPOUNDING; DRUG EVALUATION, PRECLINICAL; INFLAMMATION; LIPOSOMES; MALE; MATERIALS TESTING; RATS;

EID: 44849122618     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-007-9028-2     Document Type: Article

References (35)

1. H. Bunjes, and M. H. J. Koch. Saturated phospholipids promote crystallization but slow down polymorphic transitions in triglyceride nanoparticles. J. Control. Release. 107:229-243 (2005).
2. R. Valjakka-Koskela, M. Kirjavainen, J. Monkkonen, A. Urtti, and J. Kiesvaara. Enhancement of percutaneous absorption of naproxen by phospholipids. Int. J. Pharm. 175:225-230 (1998).
3. E. B. Souto, S. A. Wissing, C. M. Barbosa, and R. H. Muller. Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery. Int. J. Pharm. 278:71-77 (2004).
4. A. J. Domb, L. Bergelson, and S. Amselem. Lipospheres for controlled delivery of substances. Microencapsulation, methods and industrial applications, Marcel Dekker, New York, NY, 1996, pp. 377-410.
5. P. A. Insel. Analgesic-antipyretics and anti-inflammatory agents: Drugs employed in the treatment of rheumatoid arthritis and gout. In L. S. Goodman, A. Gilman, T. W. Rall, A. S. Nies, and P. Taylor (eds.), The pharmacological basis of therapeutics, McGraw-Hill International editions, New York, NY, 1992, pp. 638-681.
6. A. Domb and M. Maniar, Inventors. Liposphere delivery systems for local anesthetics. US patent 5 227 165. July 13, 1993.
7. D. B. Masters and A. J. Domb. Liposphere local anesthetic timed-release for perineural site application. Pharm. Res. 15:1038-1045 (1998).
8. V. Iannuccelli, N. Sala, R. Tursilli, G. Coppi, and S. Scalia. Influence of liposphere preparation on butyl-methoxydibenzoyl methane photostability. Eur. J. Pharm. Biopharm. 63:140-145 (2006).
9. R. Tursilli, A. Casolari, V. Iannuccelli, and S. Scalia. Enhancement of melatonin photostability by encapsulation in lipospheres. J. Pharm. Biomed. Anal. 40:910-914 (2006).
10. I. El Gibaly, and S. K. Abdel-Ghaffar. Effect of hexacosanol on the characteristics of novel sustained release allopurinol solid lipospheres (SLS): Factorial design application and product evaluation. Int. J. Pharm. 294:33-51 (2005).
11. S. Toongsuwan, L. Li, B. K. Erickson, and H. Chang. Formulation and characterization of bupivacaine lipospheres. Int. J. Pharm. 280:57-65 (2004).
12. R. R. Habashy, A. B. Abdel-Naim, A. E. Khalifa, and M. M. Al-Azizi. Anti-inflammatory effects of jojoba liquid wax in experimental models. Pharmacol. Res. 51:95-105 (2005).
13. Z. Mei, H. Chen, T. Weng, Y. Yang, and X. Yang. Solid lipid nanoparticles and microemulsion for topical delivery of triptolide. Eur. J. Pharm. Biopharm. 56:189-196 (2003).
14. H. Reithmeier, J. Herrmann, and A. Gopferich. Development and characterization of lipid microparticles as a drug carrier for somatostatin. Int. J. Pharm. 218:133-143 (2001).
15. M. Maniar, D. Hannibal, S. Amselem, X. Xie, R. Burch, and A. Domb. Characterization of Lipospheres ™-1: Effect of carrier and phospholipid on the loading of drug into the lipospheres. Pharm. Res. 8 suppl.: S-185 (1991).
16. N. S. Barakat, and A. E. B. Yassin. In vitro characterization of carbamazepine-loaded precifac lipospheres. Drug Delivery 13:95-104 (2006).
17. R. Cortesi, E. Esposito, G. Luca, and C. Nastruzzi. Production of lipospheres as carriers for bioactive compounds. Biomaterials 23:2283-2294 (2002).
18. R. M. Abra, P. J. Mihalko, and H. Schreier. The effect of lipid composition upon the encapsulation and in vitro leakage of metaproterenol sulfate from 0.2 μm diameter, extruded, multilamellar liposomes. J. Control. Release. 14:71-78 (1990).
19. T. Nii, and F. Ishii. Encapsulation efficiency of water-soluble and insoluble drugs in liposomes prepared by the microencapsulation vesicle method. Int. J. Pharm. 298:198-205 (2005).
20. B. D. Kim, K. Na, and H. K. Choi. Preparation and characterization of solid lipid nanoparticles (SLN) made of cacao butter and curdlan. Eur. J. Pharm. Sci. 24:199-205 (2005).
21. E. Escribano, A. C. Calpena, J. Queralt, R. Obach, and J. Domenech. Assessment of diclofenac permeation with different formulations: anti-inflammatory study of a selected formula. Eur. J. Pharm Sci. 19:203-210 (2003).
22. Y. Iscan, S. Hekimoglu, M. F. Sargon, and A. A. Hincal. Deet-loaded solid lipid particles for skin delivery: In vitro release and skin permeation characteristics in different vehicles. J. Microencapsul. 23:315-327 (2006).
23. T. Bekerman, J. Golenser, and A. Domb. Cyclosporin nanoparticulate lipospheres for oral administration. J. Pharm. Sci. 93:1264-1270 (2004).
24. D. Hou, C. Xie, K. Huang, and C. Zhu. The production and characteristics of solid lipid nanoparticles (SLNs). Biomaterials 24:1781-1785 (2003).
25. S. Budavari, M. J. O'Neil, A. Smith, P. E. Heckelman, J. F. Kinneary (eds.) The Merck Index, an Encyclopedia of Chemicals, Drugs and Biologicals. Whitehouse station, NJ, Merck and Co., 1996.
26. S. Scalia, R. Tursilli, N. Sala, and V. Iannuccelli. Encapsulation in lipospheres of the complex between butyl methoxydibenzoylmethane and hydroxypropyl-β-cyclodextrin. Int. J. Pharm. 320:79-85 (2006).
27. B. Vora, A. J. Khopade, and N. K. Jain. Proniosome based transdermal delivery of levonorgesterol for effective contraception. J. Control. Release. 54:149-165 (1998).
28. H. Schreier, M. Levy, and P. Mihalko. Sustained release of liposome-encapsulated gentamycin and fate of phospholipid following intramuscular injection in mice. J. Control. Release. 5:187-192 (1987).
29. A. Lippacher, R. H. Muller, and K. Mader. Preparation of semisolid drug carriers for topical application based on solid lipid nanoparticles. Int. J. Pharm. 214:9-12 (2001).
30. H. Robson, D. Q. M. Craig, and D. Deutsch. An investigation into the release of cefuroxime axetil from taste-masked stearic acid microspheres II. The effects of buffer composition on drug release. Int. J. Pharm. 195:137-145 (2000).
31. R. H. Muller, M. Radtke, and S. A. Wissing. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv. Drug Deliv. Rev. 54:S131-S155 (2002).
32. S. A. Wissing, O. Kayser, and R. H. Muller. Solid lipid nanoparticles for parentral drug delivery. Adv. Drug Deliv. Rev. 56:1257-1272 (2004).
33. A. Lippacher, R. H. Muller, and K. Mader. Semisolid SLN™ dispersions for topical application influence of formulation and production parameters on viscoelastic properties. Eur. J. Pharm. Biopharm. 53:155-160 (2002).
34. E. B. Souto, R. H. Muller, and S. Gohla. A novel approach based on lipid nanoparticles (SLN ®) for topical delivery of a-lipoic acid. J. Microencapsul. 22:581-592 (2005).
35. A. Bhatia, R. Kumar, and O. P. Katare. Tamoxifen in topical liposomes: development, characterization and in-vitro evaluation. J. Pharm. Pharmaceut. Sci. 7:252-259 (2004).